As of 9:58 AM, the stock was trading at ₹2,107.55, marking a significant increase of ₹138.70 or 7.04% from its previous close. This surge propelled the stock to breach its previous 52-week high, setting a new record at ₹2,075.65.
The day’s trading began on a strong note, with the stock opening at ₹1,972.00, slightly above its previous close of ₹1,968.85. As the morning progressed, it gained momentum, reaching an intraday high of ₹2,114.00.
Notably, this marks the third consecutive day of gains for Caplin Point Pharmaceuticals. Over this three-day period, the stock has delivered an impressive return of 9.29% to investors, showcasing sustained buying interest.
The trading volume has also seen a substantial uptick, with 7,20,730 shares changing hands by mid-morning. This increased volume suggests heightened investor activity and interest in the stock.
While specific reasons for the rally were not immediately clear, the pharmaceutical sector has been in focus recently due to various factors including regulatory developments, new product launches, and export opportunities.